Advanced Materials Technologies,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 11, 2024
Abstract
Organ‐on‐chip
(OoC)
systems
are
microfluidic
in
vitro
platforms
constructed
to
expand
the
current
understanding
of
organ‐level
physiology
and
response.
This
technology
holds
significant
potential
transform
drug
discovery,
precision
medicine,
disease
modeling
while
reducing
animal
model
use.
Recent
developments
OoC
have
shown
great
promise,
demonstrated
using
relatively
simple
designs.
Currently,
consensus
OoC‐related
literature
is
that
future
lies
development
robust
offer
higher
throughput,
improved
customization,
levels
integration
sensing
actuation
modalities.
The
implementation
silicon
micro‐nanofabrication
technologies
can
foster
such
a
transition,
but
application
field
remains
limited.
In
this
review,
an
overview
provided
been
or
be
applied
realization
compact
systems,
with
focus
on
integrated
Emerging
highlighted
for
heterogeneous
silicon‐based
polymer‐based
components
multimodal
platforms.
Finally,
most
promising
avenues
outlined
within
framework
biomedical
research
personalized
medicine.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 12, 2024
Abstract
Developing
diagnostics
and
treatments
for
neurodegenerative
diseases
(NDs)
is
challenging
due
to
multifactorial
pathogenesis
that
progresses
gradually.
Advanced
in
vitro
systems
recapitulate
patient-like
pathophysiology
are
emerging
as
alternatives
conventional
animal-based
models.
In
this
review,
we
explore
the
interconnected
pathogenic
features
of
different
types
ND,
discuss
general
strategy
modelling
NDs
using
a
microfluidic
chip,
introduce
organoid-on-a-chip
next
advanced
relevant
model.
Lastly,
overview
how
these
models
being
applied
academic
industrial
drug
development.
The
integration
chips,
stem
cells,
biotechnological
devices
promises
provide
valuable
insights
biomedical
research
developing
diagnostic
therapeutic
solutions
NDs.
Biosensors,
Journal Year:
2023,
Volume and Issue:
13(7), P. 719 - 719
Published: July 7, 2023
We
present
a
critical
review
of
the
current
progress
in
wearable
insulin
biosensors.
For
over
40
years,
glucose
biosensors
have
been
used
for
diabetes
management.
Measurement
blood
is
an
indirect
method
calculating
administration
dosage,
which
insulin-dependent
diabetic
patients.
Research
and
development
efforts
aiming
towards
continuous-insulin-monitoring
combination
with
existing
are
expected
to
offer
more
accurate
estimation
sensitivity,
regulate
dosage
facilitate
reliable
artificial
pancreas,
as
ultimate
goal
management
personalised
medicine.
Conventional
laboratory
analytical
techniques
detection
expensive
time-consuming
lack
real-time
monitoring
capability.
On
other
hand,
point-of-care
testing,
continuous
monitoring,
miniaturisation,
high
specificity
rapid
response
time,
ease
use
low
costs.
Current
research,
future
developments
challenges
biosensor
technology
reviewed
assessed.
Different
categories
such
aptamer-based,
molecularly
imprinted
polymer
(MIP)-based,
label-free
types
presented
among
latest
field.
This
multidisciplinary
field
requires
engagement
between
scientists,
engineers,
clinicians
industry
addressing
commercial,
reliable,
real-time-monitoring
biosensor.
Deleted Journal,
Journal Year:
2023,
Volume and Issue:
1(1)
Published: Aug. 1, 2023
Abstract
Responsive
biohybrid
systems
have
the
potential
to
overcome
limitations
of
both
natural
and
artificial
machines
in
terms
efficiency,
accuracy,
functionality.
As
functional
units,
living
cells
act
as
bricks
for
building
machines,
where
extracellular
matrix
mimics
hydrogels
ideal
biological
concrete.
Combining
with
offers
unique
advantages
simulating
human
tissues
or
organs,
which
unleashes
future
systems,
thus
has
attracted
extensive
attention.
Herein,
recent
progress
cell‐laden
hydrogel‐based
responsive
is
summarized
provide
a
basic
understanding
how
these
are
built
from
bottom
up
achieve
complex
functions.
This
review
focuses
on
advanced
manufacturing
technologies
including
laden
hydrogel
matrices,
three‐dimensional
bioprinting,
microfluidic
manufacturing.
Subsequently,
innovative
applications
works,
actuators,
sensors,
engineered
materials,
presented,
along
different
triggering
mechanisms
that
highlighted.
Finally,
current
challenges
opportunities
field
addressed.
provides
perspective
hoped
inspire
fields
such
technologies,
soft
robots,
tissue
engineering.
Micromachines,
Journal Year:
2023,
Volume and Issue:
14(3), P. 532 - 532
Published: Feb. 24, 2023
The
applicability
of
a
gas-permeable,
thermoplastic
material
polymethylpentene
(PMP)
was
investigated,
experimentally
and
analytically,
for
organ-on-a-chip
(OoC)
long-term
on-a-chip
cell
cultivation
applications.
Using
sealed
culture
chamber
device
fitted
with
oxygen
sensors,
we
tested
compared
PMP
to
commonly
used
glass
polydimethylsiloxane
(PDMS).
We
show
that
PDMS
have
comparable
performance
supply
during
4
days
epithelial
(A549)
cells
concentration
stabilizing
at
16%,
control
where
it
decreases
3%.
For
the
first
time,
transmission
light
images
growing
on
were
obtained,
demonstrating
optical
properties
are
suitable
non-fluorescent,
live
imaging.
Following
combined
imaging
calcein-AM
staining,
adherence,
proliferation,
morphology,
viability
A549
shown
be
similar
coated
poly-L-lysine.
In
contrast
PDMS,
demonstrate
film
as
thin
0.125
mm
is
compatible
high-resolution
confocal
microscopy
due
its
excellent
mechanical
stiffness.
also
found
fully
sterilization,
fixation,
permeabilization
fluorescent
staining.
envision
this
extend
range
possible
microfluidic
applications
beyond
current
state-of-the-art,
beneficial
physical
suitability
prototyping
by
different
methods.
integrated
measurement
methodology
demonstrated
in
work
transferrable
other
cell-based
studies
life-sciences
Trends in biotechnology,
Journal Year:
2023,
Volume and Issue:
41(10), P. 1282 - 1298
Published: July 5, 2023
The
skin
is
the
body's
largest
organ,
continuously
exposed
to
and
affected
by
natural
anthropogenic
nanomaterials
(materials
with
external
internal
dimensions
in
nanoscale
range).
This
broad
spectrum
of
insults
gives
rise
irreversible
health
effects
(from
corrosion
cancer).
Organ-on-chip
systems
can
recapitulate
physiology
high
fidelity
potentially
revolutionize
safety
assessment
nanomaterials.
Here,
we
review
current
advances
skin-on-chip
models
their
potential
elucidate
biological
mechanisms.
Further,
strategies
are
discussed
on-chip,
improving
control
over
exposure
transport
across
cells.
Finally,
highlight
future
opportunities
challenges
from
design
fabrication
acceptance
regulatory
bodies
industry.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 7, 2025
Advances
in
tissue
engineering
and
microfluidic
technologies
have
enabled
the
development
of
sophisticated
vitro
models
known
as
organ-on-a-chip
(OoC)
or
microphysiological
systems.
These
systems
enable
to
potential
simulate
dynamic
interactions
between
host
tissues
their
microenvironment
including
microbes,
biomaterials,
mechanical
forces,
pharmaceutical,
consumer-care
products.
fluidic
are
increasingly
being
utilized
investigate
host-microbe
host-material
oral
health
disease.
Of
interest
is
application
understanding
periodontal
disease,
a
chronic
inflammatory
condition
marked
by
progressive
destruction
tissues,
gingiva,
ligament,
alveolar
bone.
The
pathogenesis
disease
involves
complex
interplay
microbial
dysbiosis
immune
responses,
which
can
lead
loss
dental
support
structures
contribute
systemic
conditions
such
cardiovascular
diabetes,
bowel
This
provides
comprehensive
overview
latest
developments
millifluidic
designed
emulate
interactions.
We
discuss
critical
biological
considerations
designing
these
platforms,
applications
studying
biofilms,
unravel
mechanisms
therapeutic
targets
Journal of Biomedical Materials Research Part A,
Journal Year:
2025,
Volume and Issue:
113(2)
Published: Feb. 1, 2025
Organs-on-a-chip
(OOC)
are
an
emergent
technology
that
bridge
the
gap
between
current
in
vitro
and
vivo
models
used
to
inform
drug
discovery
investigate
disease
pathophysiology.
These
systems
offer
improved
bio-relevance
controlled
complexity
through
integration
of
physical
and/or
chemical
stimuli
matched
physiologically
relevant
conditions.
Although
significant
advancements
have
been
made
toward
recreating
organ-specific
physiology
on
chip,
methods
available
study
structure
function
cell
microenvironment
still
limited.
Established
analysis
approaches,
including
fluorescence
microscopy,
rely
laborious
offline
workflows
yield
limited
time-point
data.
As
OOC
field
continues
evolve,
there
is
a
unique
opportunity
engineer
characterization
into
organ-chip
devices.
This
review
provides
overview
integrated
sensing
approaches
address
limitations
enable
real-time
readout
physiological
parameters
OOC.
Biosensors,
Journal Year:
2025,
Volume and Issue:
15(4), P. 253 - 253
Published: April 16, 2025
The
growing
burden
of
degenerative,
cardiovascular,
neurodegenerative,
and
cancerous
diseases
necessitates
innovative
approaches
to
improve
our
pathophysiological
understanding
ability
modulate
biological
processes.
Organic
bioelectronics
has
emerged
as
a
powerful
tool
in
this
pursuit,
offering
unique
interact
with
biology
due
the
mixed
ionic–electronic
conduction
tissue-mimetic
mechanical
properties
conducting
polymers
(CPs).
These
materials
enable
seamless
integration
systems
across
different
levels
complexity,
from
monolayers
complex
3D
models,
microfluidic
chips,
even
clinical
applications.
CPs
can
be
processed
into
diverse
formats,
including
thin
films,
hydrogels,
scaffolds,
electrospun
fibers,
allowing
fabrication
advanced
bioelectronic
devices
such
multi-electrode
arrays,
transistors
(EGOFETs,
OECTs),
ion
pumps,
photoactuators.
This
review
examines
CP-based
vivo
vitro
microphysiological
systems,
focusing
on
their
monitor
key
events,
electrical
activity,
metabolic
changes,
biomarker
concentrations,
well
potential
for
electrical,
mechanical,
chemical
stimulation.
We
highlight
versatility
biocompatibility
role
advancing
personalized
medicine
regenerative
therapies
discuss
future
directions
organic
bridge
gap
between
electronic
technologies.